• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从草药提取物筛选中发现的一种新型G蛋白偶联受体的G蛋白偏向性和亚型选择性激动剂。

A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts.

作者信息

Zhang Bingjie, Zhao Simeng, Yang Dehua, Wu Yiran, Xin Ye, Cao Haijie, Huang Xi-Ping, Cai Xiaoqing, Sun Wen, Ye Na, Xu Yueming, Peng Yao, Zhao Suwen, Liu Zhi-Jie, Zhong Guisheng, Wang Ming-Wei, Shui Wenqing

机构信息

iHuman Institute, ShanghaiTech University, Shanghai 201210, China.

The National Center for Drug Screening and the CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

ACS Cent Sci. 2020 Feb 26;6(2):213-225. doi: 10.1021/acscentsci.9b01125. Epub 2020 Jan 23.

DOI:10.1021/acscentsci.9b01125
PMID:32123739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7047268/
Abstract

Subtype selectivity and functional bias are vital in current drug discovery for G protein-coupled receptors (GPCRs) as selective and biased ligands are expected to yield drug leads with optimal on-target benefits and minimal side-effects. However, structure-based design and medicinal chemistry exploration remain challenging in part because of highly conserved binding pockets within subfamilies. Herein, we present an affinity mass spectrometry approach for screening herbal extracts to identify active ligands of a GPCR, the 5-HT receptor. Using this method, we discovered a naturally occurring aporphine 1857 that displayed strong selectivity for activating 5-HT without activating the 5-HT or 5-HT receptors. Remarkably, this novel ligand exhibited exclusive bias toward G protein signaling for which key residues were identified, and it showed comparable efficacy for food intake suppression and weight loss as the antiobesity drug, lorcaserin. Our study establishes an efficient approach to discovering novel GPCR ligands by exploring the largely untapped chemical space of natural products.

摘要

亚型选择性和功能偏向性在当前针对G蛋白偶联受体(GPCR)的药物发现中至关重要,因为选择性和偏向性配体有望产生具有最佳靶标效应和最小副作用的药物先导物。然而,基于结构的设计和药物化学探索仍然具有挑战性,部分原因是亚家族内的结合口袋高度保守。在此,我们提出一种亲和质谱方法,用于筛选草药提取物以鉴定GPCR(5-羟色胺受体)的活性配体。使用这种方法,我们发现了一种天然存在的阿朴啡1857,它对激活5-羟色胺具有很强的选择性,而不会激活5-羟色胺或5-羟色胺受体。值得注意的是,这种新型配体对G蛋白信号传导表现出独特的偏向性,并且确定了关键残基,它在抑制食物摄入和减肥方面显示出与抗肥胖药物氯卡色林相当的功效。我们的研究建立了一种通过探索天然产物中很大程度上未被开发的化学空间来发现新型GPCR配体的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/276aa305ebd6/oc9b01125_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/72fe58a4269b/oc9b01125_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/30823073ac86/oc9b01125_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/36f73dbe6696/oc9b01125_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/1272657f7a47/oc9b01125_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/276aa305ebd6/oc9b01125_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/72fe58a4269b/oc9b01125_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/30823073ac86/oc9b01125_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/36f73dbe6696/oc9b01125_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/1272657f7a47/oc9b01125_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9cb/7047268/276aa305ebd6/oc9b01125_0005.jpg

相似文献

1
A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts.从草药提取物筛选中发现的一种新型G蛋白偶联受体的G蛋白偏向性和亚型选择性激动剂。
ACS Cent Sci. 2020 Feb 26;6(2):213-225. doi: 10.1021/acscentsci.9b01125. Epub 2020 Jan 23.
2
Discovery of GPCR ligands for probing signal transduction pathways.用于探究信号转导途径的GPCR配体的发现。
Front Pharmacol. 2014 Nov 28;5:255. doi: 10.3389/fphar.2014.00255. eCollection 2014.
3
Identification of natural products as novel ligands for the human 5-HT receptor.鉴定天然产物作为人5-羟色胺受体的新型配体。
Biophys Rep. 2018;4(1):50-61. doi: 10.1007/s41048-018-0047-1. Epub 2018 Mar 9.
4
Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.G 蛋白偶联受体的偏激动效应:机遇与挑战——从药物化学角度看。
Med Res Rev. 2014 Nov;34(6):1286-330. doi: 10.1002/med.21318. Epub 2014 May 5.
5
GPCR crystal structures: Medicinal chemistry in the pocket.G蛋白偶联受体晶体结构:口袋中的药物化学
Bioorg Med Chem. 2015 Jul 15;23(14):3880-906. doi: 10.1016/j.bmc.2014.12.034. Epub 2014 Dec 24.
6
GPCR structure and function relationship: identification of a biased apelin receptor mutant.G 蛋白偶联受体结构与功能关系:偏倚性阿片肽受体突变体的鉴定。
Biochem J. 2018 Dec 6;475(23):3813-3826. doi: 10.1042/BCJ20180740.
7
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.G 蛋白偶联受体(GPCRs)的偏性配体:结构-功能选择性关系(SFSRs)和治疗潜力。
J Med Chem. 2018 Nov 21;61(22):9841-9878. doi: 10.1021/acs.jmedchem.8b00435. Epub 2018 Jul 10.
8
Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.实现“偏向性”G蛋白偶联受体激动作用的前景
Mol Pharmacol. 2015 Sep;88(3):579-88. doi: 10.1124/mol.115.099630. Epub 2015 Jul 1.
9
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.G 蛋白偶联受体(GPCR)的偏向信号传导:GPCR/转导器选择性和治疗潜力的分子决定因素。
Pharmacol Ther. 2019 Aug;200:148-178. doi: 10.1016/j.pharmthera.2019.05.006. Epub 2019 May 8.
10
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.高亲和力激动剂结合与人血清素5-HT2A和5-HT2C受体的效能(内在活性)相关:支持激动剂作用的三元复合物和双态模型的证据。
J Neurochem. 1999 May;72(5):2127-34. doi: 10.1046/j.1471-4159.1999.0722127.x.

引用本文的文献

1
Emerging paradigms for target discovery of traditional medicines: A genome-wide pan-GPCR perspective.传统药物靶点发现的新兴模式:全基因组泛G蛋白偶联受体视角
Innovation (Camb). 2025 Jan 17;6(3):100774. doi: 10.1016/j.xinn.2024.100774. eCollection 2025 Mar 3.
2
Post-translational modifications orchestrate the intrinsic signaling bias of GPR52.翻译后修饰调控GPR52的内在信号偏向性。
Nat Chem Biol. 2025 Mar 14. doi: 10.1038/s41589-025-01864-w.
3
Endogenous cell membrane interactome mapping for the GLP-1 receptor in different cell types.

本文引用的文献

1
Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor.加速基于亲和质谱的配体筛选速度,以获得 G 蛋白偶联受体。
Anal Chem. 2019 Jul 2;91(13):8162-8169. doi: 10.1021/acs.analchem.9b00477. Epub 2019 Jun 12.
2
Efficient ligand discovery from natural herbs by integrating virtual screening, affinity mass spectrometry and targeted metabolomics.通过整合虚拟筛选、亲和质谱和靶向代谢组学,从天然草药中高效发现配体。
Analyst. 2019 May 7;144(9):2881-2890. doi: 10.1039/c8an02482k. Epub 2019 Feb 21.
3
Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue.
不同细胞类型中胰高血糖素样肽-1受体的内源性细胞膜相互作用组图谱绘制
Nat Chem Biol. 2025 Feb;21(2):256-267. doi: 10.1038/s41589-024-01714-1. Epub 2024 Sep 3.
4
G protein-coupled receptors and traditional Chinese medicine: new thinks for the development of traditional Chinese medicine.G蛋白偶联受体与传统中药:传统中药发展的新思考
Chin Med. 2024 Jul 2;19(1):92. doi: 10.1186/s13020-024-00964-4.
5
Identification of Spiro[chromene-2,4'-piperidine]s as Potent, Selective, and G-Biased 5-HT Receptor Partial Agonists.螺[色烯-2,4'-哌啶]类化合物作为强效、选择性且G蛋白偏向性5-羟色胺受体部分激动剂的鉴定
ACS Med Chem Lett. 2023 Dec 18;15(1):99-106. doi: 10.1021/acsmedchemlett.3c00454. eCollection 2024 Jan 11.
6
Extract Potentiates the Effect of Melatonin on Human Melatonin MT and MT Receptors with Functional Selectivity.提取物通过功能选择性增强褪黑素对人褪黑素MT和MT受体的作用。
Pharmaceutics. 2023 Jun 28;15(7):1845. doi: 10.3390/pharmaceutics15071845.
7
Exploring new targets and chemical space with affinity selection-mass spectrometry.利用亲和选择质谱法探索新靶点和化学空间。
Nat Rev Chem. 2021 Jan;5(1):62-71. doi: 10.1038/s41570-020-00229-2. Epub 2020 Oct 21.
8
Affinity selection of double-click triazole libraries for rapid discovery of allosteric modulators for GLP-1 receptor.双点击三唑文库的亲和筛选,快速发现 GLP-1 受体的变构调节剂。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2220767120. doi: 10.1073/pnas.2220767120. Epub 2023 Mar 9.
9
Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances.揭示中药方剂疗效之谜:药效物质研究的新方法与新技术
Arab J Chem. 2022 Nov;15(11):104302. doi: 10.1016/j.arabjc.2022.104302. Epub 2022 Sep 27.
10
Inhibitors Targeting Multiple Janus Kinases From Mediate Inhibition and Apoptosis Against Gastric Cancer Cells the Estrogen Pathway.靶向雌激素途径中多种 Janus 激酶的抑制剂介导对胃癌细胞的抑制和凋亡作用
Front Chem. 2022 Jun 6;10:922110. doi: 10.3389/fchem.2022.922110. eCollection 2022.
筛选美国食品药品监督管理局批准的药物,发现舒尼替尼是棕色脂肪组织 UCP1 表达的调节剂。
EBioMedicine. 2018 Nov;37:344-355. doi: 10.1016/j.ebiom.2018.10.019. Epub 2018 Oct 20.
4
Structural determinants of 5-HT receptor activation and biased agonism.5-HT 受体激活和偏向激动的结构决定因素。
Nat Struct Mol Biol. 2018 Sep;25(9):787-796. doi: 10.1038/s41594-018-0116-7. Epub 2018 Aug 20.
5
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.G 蛋白偶联受体(GPCRs)的偏性配体:结构-功能选择性关系(SFSRs)和治疗潜力。
J Med Chem. 2018 Nov 21;61(22):9841-9878. doi: 10.1021/acs.jmedchem.8b00435. Epub 2018 Jul 10.
6
High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening.通过亲和质谱筛选高通量鉴定G蛋白偶联受体调节剂
Chem Sci. 2018 Feb 20;9(12):3192-3199. doi: 10.1039/c7sc04698g. eCollection 2018 Mar 28.
7
Nanoscale synthesis and affinity ranking.纳米级合成与亲和排序。
Nature. 2018 May;557(7704):228-232. doi: 10.1038/s41586-018-0056-8. Epub 2018 Apr 23.
8
Identification of natural products as novel ligands for the human 5-HT receptor.鉴定天然产物作为人5-羟色胺受体的新型配体。
Biophys Rep. 2018;4(1):50-61. doi: 10.1007/s41048-018-0047-1. Epub 2018 Mar 9.
9
5-HT Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.5-HT 受体结构揭示了 G 蛋白偶联受体多效性的结构基础。
Cell. 2018 Feb 8;172(4):719-730.e14. doi: 10.1016/j.cell.2018.01.001. Epub 2018 Feb 1.
10
A strategy for screening of α-glucosidase inhibitors from Morus alba root bark based on the ligand fishing combined with high-performance liquid chromatography mass spectrometer and molecular docking.基于配体垂钓结合高效液相色谱质谱联用和分子对接的桑叶根皮α-葡萄糖苷酶抑制剂的筛选策略。
Talanta. 2018 Apr 1;180:337-345. doi: 10.1016/j.talanta.2017.12.065. Epub 2017 Dec 22.